Evidence map›Paper›PMID 30406935›Full record

ArticleCardiology journal2020

Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

Piotr Korczyński, Katarzyna Górska, Damian Konopka, Dżamila Al-Haj, Krzysztof J Filipiak, Rafał Krenke

Registry-linked trialAbstract read
In one paragraph

Article in Cardiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05945043 (Continuation Of a Study to Investigate the Effect of Thoracocentesis on Neural Respiratory Drive in Pleural Effusion), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05945043 recruitingnot on this mapstarted 2023, after this paper: background citation

Continuation Of a Study to Investigate the Effect of Thoracocentesis on Neural Respiratory Drive in Pleural Effusion (COSINE)

TypeobservationalSponsorGuy's and St Thomas' NHS Foundation TrustRan2023 to 2027Enrolled124ConditionsPleural EffusionArmsSurface parasternal eletromyogram, Surface diaphragm electromyogram, Parasternal muscle ultrasound, Breathlessness assessment
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Piotr KorczyńskiDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland.
Katarzyna GórskaDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland. drkpgorska@gmail.com.
Damian KonopkaStudents' Research Group "Alveolus", Medical University of Warsaw, Poland.
Dżamila Al-HajStudents' Research Group "Alveolus", Medical University of Warsaw, Poland.
Krzysztof J FilipiakDepartment of Cardiology, Medical University of Warsaw, Poland.
Rafał KrenkeDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological data on the causes of pleural effusion (PE) are scarce. Data on the local prevalence of various causes of PE may play a crucial role in the management strategy of patients with PE. The aim of the study was to investigate the causes of PE and to assess 30-day mortality rate in unselected adult patients treated in a large, multidisciplinary hospital.

methodsRetrospective analysis of medical records, including chest radiographs, of 2835 consecutive patients admitted to the hospital was performed. Radiograhic signs of PE were found in 195 of 1936 patients in whom chest radigraphs were available. These patients formed the study group.

resultsThe leading causes of PE were as follows: congestive heart failure (CHF; 37.4%), pneumonia (19.5%), malignancy (15.4%), liver cirrhosis (4.2%) and pulmonary embolism. The cause of PE in 6.7% patients was not established. There was a significant predominance of small volume PE as compared to a moderate or large volume PEs (153, 28 and 14 patients, respectively). Almost 80% of patients with CHF presented with small volume PE, while almost 50% of patients with malignant PE demonstrated moderate or large volume PE. Thirty-day mortality rate ranged from 0% for tuberculous pleurisy to 40% for malignant PE (MPE).

conclusionsPleural effusion was found in 10.1% of patients treated in a large multidisciplinary hospital. CHF was the leading cause of PE. Although 30-day mortality in patients with CHF was rela-tively high, it was lower than that in parapneumonic PE and MPE.

Indexed as

Hospitals, TeachingAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHeart FailureHumansLiver CirrhosisMaleMiddle AgedPilot ProjectsPleural EffusionPleural Effusion, MalignantPneumoniaPolandcancercongestive heart failureepidemiologypleural effusionpleuriticpneumoniatuberculosis

Identifiers

PMID30406935
PMCPMC8015984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.